CVS Health SEC filings, summarized
We read every CVS Health 8-K filing and insider trade the night it hits SEC EDGAR, and turn it into a two-minute plain-English summary.
Track CVS in your inbox
Add CVS Health to your watchlist — free, every morning.
Recent filings
CVS appoints JPMorgan executive to board as Larry Robbins departs
CVS Health appointed Teresa Heitsenrether, JPMorgan Chase’s chief data and analytics officer, to its board effective November 18, 2026. Larry Robbins, a…
CVS names JPMorgan executive Teresa Heitsenrether to board
CVS Health appointed Teresa Heitsenrether, JPMorgan Chase’s executive vice president and chief data and analytics officer, to its board effective November…
CVS Health raises 2026 guidance after second-quarter revenue and earnings growth
CVS Health reported second-quarter 2026 revenue of $106.1 billion, up 7.3% from a year earlier, while GAAP diluted EPS rose to $2.31 from $0.80 and adjusted…
CVS Health ($CVS) elected John E.
CVS Health ($CVS) elected John E. Gallina to its Board effective Mar 19, 2026. Age 66. Board found him independent and appointed him to the Audit Committee,…
CVS filed Form 8‑K (Item 9.01) on Feb 10, 2026 — exhibits: Press Release (Ex.
CVS filed Form 8‑K (Item 9.01) on Feb 10, 2026 — exhibits: Press Release (Ex. 99.1) furnished under Item 2.02 and Interactive XBRL cover page (Ex. 104). ✅…
On Feb 10, 2026 CVS Health issued a press release with results for the three months and full year ended…
On Feb 10, 2026 CVS Health issued a press release with results for the three months and full year ended Dec 31, 2025. The release is furnished as Exhibit…